Effects of Lantigen B on Salivary Secretory Immunoglobulin A Level of Children with Recurrent Respiratory Infection

方红,金红芳,董永绥,王宏伟

DOI: https://doi.org/10.3969/j.issn.1003-515x.2004.06.010

2004-01-01

Testowy IndexCopernicus

Abstract:Objective To study the activation of Lantigen B on the respiratory mucous immune response and the precaution of recurrent respiratory infection in children.Methods Thirty-five outpatients were selected and divided into 3 groups according to their ages : 1 year (n= 4); 1-3 years(n=18); 3 years (n=13). Lantigen B was used to prevent respiratory infection. During the procedure, the number, duration and severity of recurrence and adverse effects were evaluated based on the records of parents or clinical follow-up. Saliva samples were collected before and after the procedure respectively. Salivary secretory immunoglobulin A(sIgA) was determined by RIA (DAB-PEG methods) and the increase ratio of salivary sIgA was counted.Results Lantigen B improved the salivary sIgA levels and reduced the number, duration and severity of respiratory infection markedly. The increase ratio of salivary sIgA was largest in 1 year group, medium in 3 years group, the lowest in 1-3 years group. There was slight adverse effect during the treatment.Conclusion Lantigen B can activate the respiratory mucous immune response and prevent respiratory infection efficiently.